Looking at my notes and well we sure are due for some news on some significant milestones...
1. Analysis of samples from Janssen clinical trial stated as due 'mid-year'. 2. Mexico & Spain commercial roll-out stated as 'June Quarter'. 3. Giardia POC and Endometrosis POC stated as 'being finalized' 4. US Commercial partner was stated as 'few months away' ..that was 6months ago. 5. New kit version of PromarkerD should secure new licensing deals in other countries
All that with $418k to start the quarter and around $2M cash on hand lines up pretty well from a fundamentals stand point.
And of course quarterly due out any day now so hope we get some updates on the milestones listed above.
PIQ Price at posting:
34.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)